RBD-homodimer, a COVID-19 subunit vaccine candidate, elicits immunogenicity and protection in rodents and nonhuman primates

The pandemic of COVID-19 caused by SARS-CoV-2 has raised a new challenges to the scientific and industrious fields after over 1-year spread across different countries. The ultimate approach to end the pandemic is the timely application of vaccines to achieve herd immunity. Here, a novel SARS-CoV-2 r...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Xiaoyan, Shi, Jian, Hu, Xue, Wu, Yan, Zeng, Liang, Yao, Yanfeng, Shang, Weijuan, Liu, Kunpeng, Gao, Ge, Guo, Weiwei, Peng, Yun, Chen, Shaohong, Gao, Xiaoxiao, Peng, Cheng, Rao, Juhong, Zhao, Jiaxuan, Gong, Cheng, Zhou, Hui, Lu, Yudong, Wang, Zili, Hu, Xiliang, Cong, WenJuan, Fang, Lijuan, Yan, Yongxiang, Zhang, Jing, Xiong, Hui, Yi, Jizu, Yuan, Zhiming, Zhou, Pengfei, Shan, Chao, Xiao, Gengfu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423076/
https://www.ncbi.nlm.nih.gov/pubmed/34493710
http://dx.doi.org/10.1038/s41421-021-00320-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423076/
https://www.ncbi.nlm.nih.gov/pubmed/34493710
http://dx.doi.org/10.1038/s41421-021-00320-y

Ejemplares similares